直近一年間の累計
アクセス数 : ?
ダウンロード数 : ?
ID 115734
著者
Iraha, Satoshi RIKEN|Kumamoto University|Kyoto University
Tu, Hung-Ya RIKEN
Yamasaki, Suguru RIKEN|Sumitomo Dainippon Pharma
Kagawa, Takahiro Animal Resources and Technical Research Center
Goto, Motohito Animal Resources and Technical Research Center
Takahashi, Riichi Animal Resources and Technical Research Center
Watanabe, Takehito RIKEN
Sugita, Sunao RIKEN
Sunagawa, Genshiro A. RIKEN
Matsuyama, Take RIKEN
Fujii, Momo RIKEN
Kuwahara, Atsushi Sumitomo Dainippon Pharma
Kishino, Akiyoshi Sumitomo Dainippon Pharma
Koide, Naoshi RIKEN
Eiraku, Mototsugu RIKEN
Tanihara, Hidenobu Kumamoto University
Takahashi, Masayo RIKEN|Kyoto University
Mandai, Michiko RIKEN
資料タイプ
学術雑誌論文
抄録
Increasing demand for clinical retinal degeneration therapies featuring human ESC/iPSC-derived retinal tissue and cells warrants proof-of-concept studies. Here, we established two mouse models of end-stage retinal degeneration with immunodeficiency, NOG-rd1-2J and NOG-rd10, and characterized disease progress and immunodeficient status. We also transplanted human ESC-derived retinal sheets into NOG-rd1-2J and confirmed their long-term survival and maturation of the structured graft photoreceptor layer, without rejection or tumorigenesis. We recorded light responses from the host ganglion cells using a multi-electrode array system; this result was consistent with whole-mount immunostaining suggestive of host-graft synapse formation at the responding sites. This study demonstrates an application of our mouse models and provides a proof of concept for the clinical use of human ESC-derived retinal sheets.
掲載誌名
Stem Cell Reports
ISSN
22136711
出版者
International Society for Stem Cell Research|Cell Press
10
3
開始ページ
1059
終了ページ
1074
発行日
2018-03-01
権利情報
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
EDB ID
出版社版DOI
出版社版URL
フルテキストファイル
言語
eng
著者版フラグ
出版社版
部局
医学系